Stay updated on IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added 'Ovarian cancer' as a keyword/related topic and linked MedlinePlus Genetics, and updated the site release version from v3.6.4 to v3.6.5.
    Difference
    0.2%
    Check dated 2026-08-08T20:26:33.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The ovarian cancer keyword and related topics/MedlinePlus Genetics were removed from the study page, reducing disease-context and access to related resources.
    Difference
    0.2%
    Check dated 2026-08-01T18:35:15.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.4, replacing the previous v3.6.3, reflecting a new deployment/version of the ClinicalTrials.gov interface.
    Difference
    0.1%
    Check dated 2026-07-25T13:21:03.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.2 to v3.6.3, signaling a minor platform update rather than a change to study content or functionality.
    Difference
    0.1%
    Check dated 2026-07-04T03:50:08.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, representing a minor metadata update rather than substantive changes to the study details.
    Difference
    0.1%
    Check dated 2026-06-26T23:54:23.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page now indicates that recruitment is closed, while new help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment label formatting updated alongside related topics and a revision note.
    Difference
    0.7%
    Check dated 2026-06-12T13:43:30.000Z thumbnail image

Stay in the know with updates to IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial page.